ReShape Lifesciences (RSLS) News Today $0.42 +0.08 (+23.89%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.38 -0.04 (-9.52%) As of 05:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period PRISM Mid-Day Movers: Weight Loss Index Gains on Positive Data, Biotech Slumps on Disappointing ResultsMay 3 at 1:51 AM | theglobeandmail.comReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation SymposiumMay 2 at 8:31 AM | globenewswire.comReShape Lifesciences amends asset purchase terms with NinjourApril 30, 2025 | investing.comReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon SystemApril 28, 2025 | finanznachrichten.deReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon SystemApril 28, 2025 | globenewswire.comReShape Lifesciences® Secures Patent for Innovative Vagal Neuromodulation Device to Treat Type 2 Diabetes with Enhanced Energy EfficiencyApril 23, 2025 | nasdaq.comReShape Lifesciences Ignites Retail Frenzy As Stock Soars On US Patent For Diabetes Neuromodulation SystemApril 22, 2025 | msn.comReShape Lifesciences skyrockets after receiving U.S. patent for diabetes neuromodulation technologyApril 21, 2025 | msn.comReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation TechnologyApril 21, 2025 | globenewswire.comReShape Lifesciences enters agreement with HaifaApril 10, 2025 | markets.businessinsider.comReShape Lifesciences Inc. (RSLS) Earnings Highlights and Strategic Business Update Conference (Transcript)April 10, 2025 | seekingalpha.comReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. MarketApril 9, 2025 | globenewswire.comReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate UpdateApril 7, 2025 | globenewswire.comReShape Lifesciences Delays Yearly Report FilingApril 1, 2025 | tipranks.comRESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLSMarch 21, 2025 | businesswire.comReShape Lifesciences® Receives Notice of Allowance for Vagus Nerve Modulation Patent Aimed at Improving Glycemic ControlMarch 12, 2025 | nasdaq.comReShape receives notice of allowance for patent related to NeuromodulationMarch 10, 2025 | markets.businessinsider.comReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation TechnologyMarch 10, 2025 | globenewswire.comReShape Lifesciences signs distribution agreement with Liaison MedicalFebruary 25, 2025 | markets.businessinsider.comReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEXFebruary 25, 2025 | globenewswire.comReShape Lifesciences 2.6M share Secondary priced at $2.33February 18, 2025 | markets.businessinsider.comReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public OfferingFebruary 15, 2025 | globenewswire.comRSLS stock touches 52-week low at $2.57 amid market challengesFebruary 13, 2025 | msn.comReShape Lifesciences granted key IP in IsraelFebruary 4, 2025 | markets.businessinsider.comReShape Lifesciences secures key diabetes treatment patentFebruary 4, 2025 | msn.comReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation TechnologyFebruary 3, 2025 | globenewswire.comRSLS Stock Touches 52-Week Low at $4.07 Amid Market ChallengesJanuary 28, 2025 | msn.com$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - RSLS, TURN, RDW, NEUEJanuary 24, 2025 | markets.businessinsider.comReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad MedisysJanuary 13, 2025 | globenewswire.comReShape Lifesciences files to sell 2.11M shares of common stock for holdersDecember 20, 2024 | markets.businessinsider.comQ3 2024 ReShape Lifesciences Inc Earnings CallNovember 16, 2024 | finance.yahoo.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comReShape Lifesciences Reports Q3 Growth and Strategic MovesNovember 16, 2024 | markets.businessinsider.comReshape Lifesciences Inc (RSLS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...November 15, 2024 | finance.yahoo.comReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comReShape Lifesciences receives Health Canada approval for Lap-Band 2.0 FLEXNovember 12, 2024 | markets.businessinsider.comReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate UpdateNovember 12, 2024 | globenewswire.comReShape secures NIH grant to develop electrodes for diabetes treatment deviceNovember 12, 2024 | finance.yahoo.comReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEXNovember 12, 2024 | globenewswire.comReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape's Proprietary Diabetes Bloc-Stim Neuromodulation™ TechnologyNovember 11, 2024 | globenewswire.comReShape Lifesciences (NASDAQ:RSLS) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?ReShape Lifesciences (NASDAQ:RSLS) Share Price Passes Above 200 Day Moving Average - Here's What HappenedOctober 18, 2024 | marketbeat.comReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 472.0% in SeptemberReShape Lifesciences Inc. (NASDAQ:RSLS - Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totalling 57,200 shares, an increase of 472.0% from the September 15th total of 10,000 shares. Currently, 12.2% of the company's stock are sold short. Based on an average daily volume of 157,500 shares, the short-interest ratio is currently 0.4 days.October 10, 2024 | marketbeat.comReShape Lifesciences (NASDAQ:RSLS) Shares Pass Above 200 Day Moving Average - Should You Sell?ReShape Lifesciences (NASDAQ:RSLS) Stock Passes Above 200-Day Moving Average - Here's What HappenedOctober 4, 2024 | marketbeat.comReshape Lifesciences (NASDAQ:RSLS) Stock, Short Interest ReportSeptember 24, 2024 | benzinga.comReshape Lifesciences (NASDAQ:RSLS) Stock Quotes, Forecast and News SummarySeptember 24, 2024 | benzinga.comUpcoming Stock Splits This Week (September 23 to September 27) – Stay InvestedSeptember 23, 2024 | msn.comReShape Lifesciences Announces 1-for-58 Reverse Stock SplitSeptember 19, 2024 | globenewswire.comNexstim Oyj (5NX.MU)August 22, 2024 | finance.yahoo.comQ2 2024 ReShape Lifesciences Inc Earnings CallAugust 16, 2024 | finance.yahoo.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | msn.com Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address RSLS Media Mentions By Week RSLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RSLS News Sentiment▼0.200.73▲Average Medical News Sentiment RSLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RSLS Articles This Week▼51▲RSLS Articles Average Week Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABT News ISRG News BSX News SYK News MDT News BDX News EW News IDXX News RMD News DXCM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RSLS) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
